. 2020 Sep 6;8(12):2827–2834. doi: 10.1002/ccr3.3271

TABLE 1.

Studies investigating the effectiveness of aripiprazole in AN

Author(s)	Publication year	Age	Number of patients	Dosage of aripiprazole	Duration	Result
Trunko et al	2011	15‐55	8 (5 with AN, 3 with BN)	5‐15 mg/d	4‐41 mo	Decrease in fear of eating, obsessional thoughts, increase in BMI
Frank	2016	12‐17	4	2‐5 mg/d	2‐4 wk	Improve in body image, decrease in fear of eating
Frank et al	2017	14.4 ^a (ARI −) 15.0 ^a (ARI +)	84 (ARI −) 22 (ARI +)	1‐5 mg/d	15.9 ^a d (ARI −) 18.9 ^a d (ARI +)	Increase in BMI, weight gain

Author(s)

Publication year

Age

Number of patients

Dosage of aripiprazole

Duration

Result

Trunko et al

2011

15‐55

8 (5 with AN, 3 with BN)

5‐15 mg/d

4‐41 mo

Decrease in fear of eating, obsessional thoughts, increase in BMI

Frank

2016

12‐17

2‐5 mg/d

2‐4 wk

Improve in body image, decrease in fear of eating

Frank et al

2017

14.4 ^a (ARI −) 15.0 ^a (ARI +)

84 (ARI −)

22 (ARI +)

1‐5 mg/d

15.9 ^a d (ARI −) 18.9 ^a d (ARI +)

Increase in BMI, weight gain

Abbreviations: AN, anorexia nervosa; ARI, aripiprazole; BMI, body mass index; BN, bulimia nervosa.

^{^a}

Mean value.